Hereditary hemochromatosis is a genetic condition that causes your body to absorb too much iron from food. Because humans have no natural way to get rid of excess iron, it builds up over years in organs like the liver, heart, pancreas, and joints, eventually causing damage if left untreated. It is most common in people of Northern European descent and is one of the most frequently inherited genetic disorders in that population.
The good news: when caught early, hereditary hemochromatosis is straightforward to manage, and most people with the condition live normal lives.
How the Genetic Defect Works
The most common form of hereditary hemochromatosis is caused by mutations in a gene called HFE. Two mutations matter most: C282Y and H63D. The vast majority of people with the condition are homozygous for C282Y, meaning they inherited a copy of this mutation from each parent.
Normally, the HFE protein helps liver cells regulate production of a hormone called hepcidin. Hepcidin acts as your body’s iron thermostat. When iron levels are high enough, hepcidin signals the gut to stop absorbing more iron from food and tells iron-recycling cells to hold onto their stores. In hereditary hemochromatosis, the mutant HFE protein fails to stabilize a key receptor on liver cells, so the signaling pathway that activates hepcidin production doesn’t work properly. The result is chronically low hepcidin levels. Without that brake signal, your intestines keep absorbing iron whether your body needs it or not, and iron accumulates in tissues year after year.
Early and Late Symptoms
Hereditary hemochromatosis develops slowly. Many people have no symptoms at all for decades, particularly women, who lose iron through menstruation and pregnancy. When symptoms do appear, they’re often vague enough to be mistaken for something else:
- Persistent fatigue or weakness that doesn’t improve with rest
- Joint pain, especially in the knuckles and knees
- Loss of sex drive or erectile dysfunction
- Abdominal pain concentrated over the liver area
Joint pain is one of the more distinctive early clues. It tends to affect the second and third knuckle joints of both hands, a pattern unusual enough that it sometimes prompts a doctor to check iron levels.
As iron overload becomes more severe, more serious signs develop. The skin may take on a gray, metallic, or bronze tone from iron deposits. Liver disease can progress to cirrhosis or liver cancer. The pancreas may sustain enough damage to cause diabetes. This combination of skin darkening and diabetes is the reason hemochromatosis was historically called “bronze diabetes.” Heart failure can also occur as iron accumulates in cardiac tissue. In the rarer juvenile form (type 2 hemochromatosis), potentially fatal heart disease can develop by age 30 if untreated.
How It’s Diagnosed
Diagnosis typically starts with two blood tests. The first is transferrin saturation, which measures how much of your blood’s iron-carrying protein is loaded with iron. A transferrin saturation above 50% suggests that a disproportionate amount of iron is being delivered to tissues that aren’t equipped to handle it. The second test is serum ferritin, which reflects how much iron your body has in storage.
If both values are elevated, the next step is genetic testing for the C282Y and H63D mutations. Finding two copies of C282Y in someone with high iron markers confirms hereditary hemochromatosis. Your doctor may also order liver imaging or, in some cases, a liver biopsy to assess whether organ damage has already occurred.
Not everyone who carries two copies of C282Y develops clinical disease. Penetrance is low, meaning a significant number of people with the genotype never accumulate enough iron to cause problems. This is why diagnosis depends on both genetic results and evidence of actual iron overload.
Treatment: Therapeutic Phlebotomy
The primary treatment is remarkably simple: regular blood removal, called therapeutic phlebotomy. Each session removes roughly a pint of blood, which forces your body to use stored iron to make new red blood cells. During the initial phase, sessions typically happen weekly or every two weeks until ferritin drops below 50 ng/mL. Depending on how much iron has built up, this induction phase can take months to over a year.
Once iron stores are depleted to a safe level, you shift to maintenance phlebotomy every three to four months to keep ferritin between 50 and 100 ng/mL. The procedure itself feels like a standard blood donation and takes about 15 to 30 minutes. Most people tolerate it well, though mild lightheadedness or fatigue afterward is common, especially early on.
When treatment begins before organ damage has occurred, outcomes are excellent. Fatigue and many other symptoms often improve. Joint pain, however, can persist even after iron levels normalize, since cartilage damage from iron deposits may not be fully reversible.
Dietary Changes That Help
Phlebotomy does the heavy lifting, but dietary adjustments can reduce how much iron you absorb between sessions.
Red meat and organ meats are the richest sources of the type of iron your body absorbs most efficiently (heme iron). Limiting red meat and choosing lean poultry instead is a practical step. One guideline suggests no more than 200 grams of meat per week, ideally from poultry, spread across about two meals. Processed meats, organ meats, and game meat (which retains more blood and therefore more iron) are best avoided.
Vitamin C supplements dramatically increase iron absorption when taken with food. If you take a multivitamin, look for one without added iron and with no more than 200 mg of vitamin C. Fresh fruit and juice are fine, but drinking them between meals rather than with meals reduces their effect on iron absorption.
Alcohol deserves special attention. Regular alcohol consumption independently increases iron overload and, in people with hemochromatosis, raises the risk of both cirrhosis and liver cancer. The safest approach is to avoid alcohol entirely. If that’s not realistic, keeping consumption to an absolute minimum makes a meaningful difference.
Screening Family Members
Because hereditary hemochromatosis follows an autosomal recessive inheritance pattern, first-degree relatives of a diagnosed person (parents, siblings, and children) have a significantly higher chance of carrying the mutations. Clinical guidelines recommend cascade screening for all first-degree relatives whenever someone is diagnosed. This involves both genetic testing and iron studies.
For children of an affected person, screening can generally wait until late adolescence. The condition’s slow progression and low penetrance mean there’s rarely urgency in childhood, and earlier testing can create unnecessary anxiety. Siblings of an affected person, however, should be tested promptly, since they have a one-in-four chance of also being homozygous for C282Y.
Catching hemochromatosis early in a family member, before iron has had decades to accumulate, is one of the most effective things genetic screening can do. A person identified through family testing who begins phlebotomy before organ damage occurs can expect a normal lifespan with minimal impact on daily life.